Biotech | March 12, 2024
USFDA grants Orphan Drug Designation for iOnctura's first-in-class autotaxin cancer therapy
It is the first autotaxin inhibitor to be investigated in cancer patients
It is the first autotaxin inhibitor to be investigated in cancer patients
Arun is currently working as Vice President (Strategy) in Solara leading Business finance & Strategy function
Group sales came in at 47.637 billion euros, down 1.2% on a currency- and portfolio-adjusted basis
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
The objective of GCMC is well aligned to WHO’s call to action and India’s National Biotechnology Development Strategy
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
Sustainability is integral to Biocon's business purpose
The agreement sets terms under which POC will manufacture the product or receive royalties
iSolveSM information on demand is the result of our focus on customer relationship
The company is committed to a new category development in areas like adult Immunization with products like Shingrix to make a positive impact to the lives of the patients in India
Subscribe To Our Newsletter & Stay Updated
